Brief: Irlab Q2 Operating Loss Narrows To SEK 26.1 Mln

IRLAB Therapeutics AB

26/08/2020 06:58

Aug 26 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * Q2 OPERATING LOSS SEK 26.1 MILLION VERSUS LOSS SEK 30.4
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr9xzmlG 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))